Home > Publications Database > Review-Emerging Portable Technologies for Gait Analysis in Neurological Disorders. > print

001     163320
005     20230915090517.0
024 7 _ |a 10.3389/fnhum.2022.768575
|2 doi
024 7 _ |a pmid:35185496
|2 pmid
024 7 _ |a pmc:PMC8850274
|2 pmc
024 7 _ |a altmetric:122048157
|2 altmetric
037 _ _ |a DZNE-2022-00100
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Salchow-Hömmen, Christina
|b 0
245 _ _ |a Review-Emerging Portable Technologies for Gait Analysis in Neurological Disorders.
260 _ _ |a Lausanne
|c 2022
|b Frontiers Research Foundation
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1654866129_23357
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The understanding of locomotion in neurological disorders requires technologies for quantitative gait analysis. Numerous modalities are available today to objectively capture spatiotemporal gait and postural control features. Nevertheless, many obstacles prevent the application of these technologies to their full potential in neurological research and especially clinical practice. These include the required expert knowledge, time for data collection, and missing standards for data analysis and reporting. Here, we provide a technological review of wearable and vision-based portable motion analysis tools that emerged in the last decade with recent applications in neurological disorders such as Parkinson's disease and Multiple Sclerosis. The goal is to enable the reader to understand the available technologies with their individual strengths and limitations in order to make an informed decision for own investigations and clinical applications. We foresee that ongoing developments toward user-friendly automated devices will allow for closed-loop applications, long-term monitoring, and telemedical consulting in real-life environments.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Parkinson's disease
|2 Other
650 _ 7 |a digital image processing
|2 Other
650 _ 7 |a human kinematics
|2 Other
650 _ 7 |a locomotion
|2 Other
650 _ 7 |a motion tracking
|2 Other
650 _ 7 |a multiple sclerosis
|2 Other
650 _ 7 |a postural control
|2 Other
650 _ 7 |a wearables
|2 Other
700 1 _ |a Skrobot, Matej
|b 1
700 1 _ |a Jochner, Magdalena C E
|b 2
700 1 _ |a Schauer, Thomas
|b 3
700 1 _ |a Kühn, Andrea A
|0 P:(DE-2719)2811089
|b 4
|u dzne
700 1 _ |a Wenger, Nikolaus
|b 5
773 _ _ |a 10.3389/fnhum.2022.768575
|g Vol. 16, p. 768575
|0 PERI:(DE-600)2425477-0
|p 768575
|t Frontiers in human neuroscience
|v 16
|y 2022
|x 1662-5161
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/163320/files/DZNE-2022-00100.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/163320/files/DZNE-2022-00100.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:163320
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)2811089
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2022
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-27
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-27
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2021-01-27
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2021-01-27
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b FRONT HUM NEUROSCI : 2021
|d 2022-11-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2021-05-04T10:58:52Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2021-05-04T10:58:52Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
|d 2021-05-04T10:58:52Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-15
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2022-11-15
920 1 _ |0 I:(DE-2719)1811005
|k AG Endres
|l Coordinator of Clinical Research
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1811005
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21